Eva Akerblom

Author PubWeight™ 5.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3. FEBS J 2007 0.92
2 Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3. Antivir Ther 2007 0.85
3 Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals. Bioorg Med Chem 2003 0.84
4 Structure-activity relationships of HCV NS3 protease inhibitors evaluated on the drug-resistant variants A156T and D168V. Antivir Ther 2010 0.81
5 Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3. Bioorg Med Chem 2005 0.80
6 Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety. Bioorg Med Chem 2007 0.78
7 Mechanistic studies of electrophilic protease inhibitors of full length hepatic C virus (HCV) NS3. J Enzyme Inhib Med Chem 2007 0.75
8 Tetrapeptides as potent protease inhibitors of Hepatitis C Virus full-length NS3 (protease-helicase/NTPase). Bioorg Med Chem 2002 0.75
9 Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors. Biochim Biophys Acta 2004 0.75